CLARANOVA SE (CLA.PA)

FR0013426004 - Common Stock

1.176  +0.01 (+0.68%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CLA. CLA was compared to 92 industry peers in the Software industry. While CLA is still in line with the averages on profitability rating, there are concerns on its financial health. CLA has a valuation in line with the averages, but it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

CLA had negative earnings in the past year.
In the past year CLA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
CLA had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of CLA (-4.90%) is worse than 70.73% of its industry peers.
CLA has a better Return On Invested Capital (21.05%) than 89.02% of its industry peers.
CLA had an Average Return On Invested Capital over the past 3 years of 16.62%. This is above the industry average of 11.85%.
The 3 year average ROIC (16.62%) for CLA is below the current ROIC(21.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.9%
ROE N/A
ROIC 21.05%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.62%
ROIC(5y)13.46%

1.3 Margins

CLA has a Operating Margin (6.82%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CLA has grown nicely.
With a Gross Margin value of 28.55%, CLA is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.82%
PM (TTM) N/A
GM 28.55%
OM growth 3Y11.39%
OM growth 5Y9.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLA is creating value.
Compared to 1 year ago, CLA has more shares outstanding
Compared to 5 years ago, CLA has more shares outstanding
Compared to 1 year ago, CLA has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.26, we must say that CLA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.26, CLA is not doing good in the industry: 71.95% of the companies in the same industry are doing better.
The Debt to FCF ratio of CLA is 4.39, which is a neutral value as it means it would take CLA, 4.39 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.39, CLA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.39
Altman-Z 1.26
ROIC/WACC3.19
WACC6.61%

2.3 Liquidity

CLA has a Current Ratio of 0.75. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.75, CLA is not doing good in the industry: 92.68% of the companies in the same industry are doing better.
CLA has a Quick Ratio of 0.75. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CLA (0.61) is worse than 93.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.61

3

3. Growth

3.1 Past

CLA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.97%.
Looking at the last year, CLA shows a decrease in Revenue. The Revenue has decreased by -2.23% in the last year.
Measured over the past years, CLA shows a quite strong growth in Revenue. The Revenue has been growing by 13.58% on average per year.
EPS 1Y (TTM)4.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.29%
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%1.25%

3.2 Future

The Earnings Per Share is expected to grow by 19.00% on average over the next years. This is quite good.
Based on estimates for the next years, CLA will show a small growth in Revenue. The Revenue will grow by 4.14% on average per year.
EPS Next Y34.59%
EPS Next 2Y36.11%
EPS Next 3Y19%
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2Y4.91%
Revenue Next 3Y4.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLA. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 4.07, which indicates a rather cheap valuation of CLA.
96.34% of the companies in the same industry are more expensive than CLA, based on the Price/Forward Earnings ratio.
CLA is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.07

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 92.68% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.95
EV/EBITDA 3.96

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLA's earnings are expected to grow with 19.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.11%
EPS Next 3Y19%

0

5. Dividend

5.1 Amount

No dividends for CLA!.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (12/24/2024, 7:00:00 PM)

1.176

+0.01 (+0.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2024-11-13
Earnings (Next)N/A N/A
Inst Owners19.07%
Inst Owner ChangeN/A
Ins Owners16.66%
Ins Owner ChangeN/A
Market Cap67.28M
Analysts74.29
Price Target3.33 (183.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.95%
PT rev (3m)-16.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-15.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.07
P/S 0.14
P/FCF 1.95
P/OCF 1.69
P/B N/A
P/tB N/A
EV/EBITDA 3.96
EPS(TTM)-0.22
EYN/A
EPS(NY)0.29
Fwd EY24.56%
FCF(TTM)0.6
FCFY51.28%
OCF(TTM)0.69
OCFY59.01%
SpS8.66
BVpS-0.17
TBVpS-2.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.9%
ROE N/A
ROCE 28.64%
ROIC 21.05%
ROICexc 30.67%
ROICexgc N/A
OM 6.82%
PM (TTM) N/A
GM 28.55%
FCFM 6.96%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.62%
ROIC(5y)13.46%
ROICexc(3y)45.4%
ROICexc(5y)36.38%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)22.61%
ROCE(5y)18.31%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y0.44%
ROICexc growth 5Y8.29%
OM growth 3Y11.39%
OM growth 5Y9.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
F-Score5
Asset Turnover2.17
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.39
Debt/EBITDA 2.66
Cap/Depr 42.98%
Cap/Sales 1.05%
Interest Coverage 250
Cash Conversion 86.49%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.61
Altman-Z 1.26
F-Score5
WACC6.61%
ROIC/WACC3.19
Cap/Depr(3y)51.75%
Cap/Depr(5y)41.72%
Cap/Sales(3y)1.22%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.29%
EPS Next Y34.59%
EPS Next 2Y36.11%
EPS Next 3Y19%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%1.25%
Revenue Next Year3.68%
Revenue Next 2Y4.91%
Revenue Next 3Y4.14%
Revenue Next 5YN/A
EBIT growth 1Y30%
EBIT growth 3Y13.32%
EBIT growth 5Y24.57%
EBIT Next Year39.46%
EBIT Next 3Y19.79%
EBIT Next 5YN/A
FCF growth 1Y2256.25%
FCF growth 3Y32.3%
FCF growth 5Y48.99%
OCF growth 1Y326.88%
OCF growth 3Y28.52%
OCF growth 5Y40.7%